Lantheus Holdings, Inc. is 4.4x more valuable than Anbio Biotechnology by market capitalization ($6.67 B vs $1.50 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LNTH | NNNN |
|---|---|---|
| Market cap | $6.67 B | $1.50 B |
| US-listed rank | #1193 | #2337 |
| Revenue (latest FY) | $1.54B | $8.65M |
| Net income (latest FY) | $233.56M | $6.40M |
| Net margin | 15.2% | 74.1% |
| P/E (trailing FY) | 28.6 | 234.2 |
| SEC filings | 1,079 | 40 |
Lantheus Holdings, Inc. is 4.4x more valuable than Anbio Biotechnology by market capitalization ($6.67 B vs $1.50 B).
In their latest fiscal years, Lantheus Holdings, Inc. reported $1.54B in revenue while Anbio Biotechnology reported $8.65M.
Full pages: Lantheus Holdings, Inc. and Anbio Biotechnology, or browse the full rankings.